Elective neck treatment in clinically node-negative paranasal sinus carcinomas: impact on treatment outcome
- Author:
Won Hee LEE
1
;
Seo Hee CHOI
;
Se Heon KIM
;
Eun Chang CHOI
;
Chang Geol LEE
;
Ki Chang KEUM
Author Information
- Publication Type:Original Article
- Keywords: Paranasal sinus carcinoma; Maxillary sinus carcinoma; Elective neck irradiation; Elective neck dissection; Locoregional recurrence; Overall survival
- MeSH: Disease-Free Survival; Follow-Up Studies; Humans; Neck; Prognosis; Treatment Outcome
- From:Radiation Oncology Journal 2018;36(4):304-316
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The indication of elective neck treatment (ENT) for clinically N0 (cN0) paranasal sinus (PNS) carcinoma remains unclear. We aimed to investigate different treatment outcomes regarding ENT and propose optimal recommendations for ENT. MATERIALS AND METHODS: We identified patients with cN0 PNS carcinoma who underwent curative-intent treatment between 1992 and 2015. Survival outcomes and pattern of failure were compared between patients who received ENT and those who did not. We sought to identify significant patient or pathologic factors regarding treatment outcomes. RESULTS: Among 124 patients meeting the inclusion criteria, 40 (32%) received ENT (‘ENT (+) group’) and 84 (68%) did not (‘ENT (−) group’). With a median follow-up of 54 months, the 5-year overall survival (OS) was 67%, and the 5-year progression-free survival (PFS) was 45%. There was no significant difference between the ENT (+) and ENT (−) groups regarding OS (p = 0.67) and PFS (p = 0.50). Neither group showed a significantly different pattern of failure, including regional failure (p = 0.91). There was no specific benefit, even in the subgroups analysis by tumor site, histologic type, and T stage. Nevertheless, patients who ever had regional and/or distant failure showed significantly worse prognosis. CONCLUSION: ENT did not significantly affect the survival outcome or pattern of failure in patients with cN0 PNS carcinomas, showing that ENT should not be generalized in this group. However, further discussion on the optimal strategy for ENT should continue because of the non-negligible regional failure rates and significantly worse prognosis after regional failure events.
